Pyxis Oncology

PYXSNASDAQ
$2.92
-0.02-0.68%
Last update: 12:09 PM
15 minutes delayed
Pyxis Oncology (PYXS) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$25.00
Lowest Price Target1
$7.00
Consensus Price Target1
$12.67

Pyxis Oncology (NASDAQ:PYXS) Stock, Analyst Ratings, Price Targets, Predictions

Pyxis Oncology Inc has a consensus price target of $12.67, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Jefferies, and HC Wainwright & Co. on May 16, 2024, May 7, 2024, and April 10, 2024. With an average price target of $8 between HC Wainwright & Co., Jefferies, and HC Wainwright & Co., there's an implied 169.36% upside for Pyxis Oncology Inc from these 3 analyst ratings.

Analyst Trends and Forecast
1
Jan
0
0
0
0
Feb
1
Mar
0
0
0
0
Apr
0
0
0
0
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Jefferies
RBC Capital
BTIG
Leerink Partners

1calculated from analyst ratings

Analyst Ratings for Pyxis Oncology

Buy NowGet Alert
05/16/2024Buy Now135.69%HC Wainwright & Co.
Swayampakula Ramakanth
 → $7ReiteratesBuy → BuyGet Alert
05/07/2024Buy Now236.7%Jefferies
Farzin Haque
 → $10AssumesBuy → BuyGet Alert
04/10/2024Buy Now135.69%HC Wainwright & Co.
Swayampakula Ramakanth
 → $7ReiteratesBuy → BuyGet Alert
03/22/2024Buy Now135.69%RBC Capital
Leonid Timashev
 → $7ReiteratesOutperform → OutperformGet Alert
03/22/2024Buy Now135.69%HC Wainwright & Co.
Swayampakula Ramakanth
$4 → $7MaintainsBuyGet Alert
02/09/2024Buy Now169.36%BTIG
Kaveri Pohlman
 → $8Initiates → BuyGet Alert
01/23/2024Buy Now304.04%Leerink Partners
Jeffrey La Rosa
 → $12Initiates → OutperformGet Alert
11/30/2023Buy Now34.68%HC Wainwright & Co.
Swayampakula Ramakanth
 → $4Initiates → BuyGet Alert
09/05/2023Buy Now135.69%RBC Capital
Leonid Timashev
 → $7Initiates → OutperformGet Alert
07/31/2023Buy Now405.05%EF Hutton
Tony Butler
 → $15Initiates → BuyGet Alert
03/23/2023Buy Now371.38%Credit Suisse
Tiago Fauth
 → $14Reiterates → OutperformGet Alert
11/02/2021Buy Now438.72%B of A Securities
Tazeen Ahmad
—Initiates → NeutralGet Alert
11/02/2021Buy Now741.75%Jefferies
Eun Yang
—Initiates → BuyGet Alert
11/02/2021Buy Now539.73%Credit Suisse
Tiago Fauth
—Initiates → OutperformGet Alert

FAQ

Q

What is the target price for Pyxis Oncology (PYXS) stock?

A

The latest price target for Pyxis Oncology (NASDAQ:PYXS) was reported by HC Wainwright & Co. on May 16, 2024. The analyst firm set a price target for $7.00 expecting PYXS to rise to within 12 months (a possible 139.73% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Pyxis Oncology (PYXS)?

A

The latest analyst rating for Pyxis Oncology (NASDAQ:PYXS) was provided by HC Wainwright & Co., and Pyxis Oncology reiterated their buy rating.

Q

When was the last upgrade for Pyxis Oncology (PYXS)?

A

There is no last upgrade for Pyxis Oncology

Q

When was the last downgrade for Pyxis Oncology (PYXS)?

A

There is no last downgrade for Pyxis Oncology.

Q

When is the next analyst rating going to be posted or updated for Pyxis Oncology (PYXS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pyxis Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pyxis Oncology was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.

Q

Is the Analyst Rating Pyxis Oncology (PYXS) correct?

A

While ratings are subjective and will change, the latest Pyxis Oncology (PYXS) rating was a reiterated with a price target of $7.00 to $7.00. The current price Pyxis Oncology (PYXS) is trading at is $2.92, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch